Type 2 Diabetes

Treatment simplification of complex insulin regimens in T2D

The SoliRam observational study

Is Premixed Insulin an Effective Treatment for Type 2 Diabetes Uncontrolled by OADs?

Glargine 300 use in people with type 2 diabetes who fast during Ramadan

ATTD 2021: Technology Supporting Initiation, Titration, and Intensification

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

ADA 2021: Solimix Trial Summary

SoliMix Study Results Summary

The ATOS Study: Real-World Study on Effectiveness of Insulin Glargine U300 in the Gulf Region.

SoliD: Redefine Treatment Paradigm Post-OAD

SoliCGM Synergy: Soliqua’s Synchronized Impact on T2DM CGM Dynamics Therapy

Groundbreaking SoliD Study: Comparative Efficacy of iGlarLixi and IDegAsp

An Evidence about The Role of Basal Insulin Glargine 300 U/mL Post-GLP-1 Therapy

Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.

Unmet needs in adults with T2D receiving premixed insulin

Insulin Treatment Intensification with GLP - 1RA vs Basal - Plus/Basal - Bolus Regimens

Effectiveness of continuous glucose monitoring in adults with Type 2 diabetes treated with basal insulin

Basal Insulin and Beyond: Advanced Therapies for Type 2 Diabetes

Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens

Advancing Therapy with iGlarLixi

Recommendations on treatment simplification of complex insulin regimens to improve clinical outcomes in patients with T2DM

Treatment simplification in T2D: A less-is-more approach to help reduce the burden of disease

New 2022 ADA/EASD Guidelines: GLPP-1 RA/Insulin Combination Is Recommended

ADA/EASD recommend considering combination injectables therapy of basal insulin/GLP-1 RA (Such as Soliqua^®) as valuable treatment option to provide adequate efficacy for achieving and maintaining glycemic goals.

iGlarLixi Enables Safe Ramadan Fasting for Most T2D Patients

Treatment simplification for adults with Type 2 diabetes